REPCF:OTCMKTS
0913693 BC Ltd
၀.၀၀၀၁၀ US$
၀.၀၀%
(၀.၀၀) 1D
စက် ၁၄, GMT-၄ ၀၉:၃၉:၄၆ · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for REPCF...
Mkt. cap
၇.၃၆ ထောင်
Avg. vol.
၁.၉၈ ထောင်
Volume
၀.၀၀
P/E ratio
၀.၀၀
52-wk high
၀.၀၀ US$
52-wk low
၀.၀၀ US$
EPS
၀.၀၉ US$
Shares outstanding
၇.၃၆ ကုဋေ
No. of employees
၁
Mkt. cap
၇.၃၆ ထောင်
Avg. vol.
၁.၉၈ ထောင်
Volume
၀.၀၀
P/E ratio
၀.၀၀
52-wk high
၀.၀၀ US$
52-wk low
၀.၀၀ US$
EPS
၀.၀၉ US$
Shares outstanding
၇.၃၆ ကုဋေ
No. of employees
၁
News stories
From web sources and news partners
GuruFocus
·
ပြီးခဲ့သည့် ၁၈ မိနစ်
CollPlant Biotechnologies (CLGN) Reports Q3 Loss, Plans Strategi
TradingView
·
ပြီးခဲ့သည့် ၂၉ မိနစ်
Key facts: NASDAQ:ASTS Seeks Expanded Spectrum; Ships BlueBird
MarketBeat
·
ပြီးခဲ့သည့် ၂၅ မိနစ်
Cadiz (NASDAQ:CDZI) Shares Cross Below 200-Day Moving Average - Time to Sell?
Yahoo Finance
·
ပြီးခဲ့သည့် ၁၁ မိနစ်
Everpure Stock Is September’s Surprise S&P 500 Winner, Surging More Than 40% As Retail Piles In
Profile
RepliCel Life Sciences is a Canadian regenerative medicine company based in Vancouver, British Columbia. The company focuses on development of cell therapies using a patient's own cells. The company has treatment development activities targeting chronic tendon injuries which have failed to heal properly, and hair restoration. The company's expertise lies in isolation and exploitation of different cell populations found in the human hair follicle.
The company's business model is focused on establishing proof-of-concept for treatments leading to acquisition by a larger company. An alternative business model has been reported which does not involve acquisition but rather partnership where technologies and methods are licensed to a partner which will commercialize them. Wikipedia
About 0913693 BC Ltd
CEO-
Employees၁
Founded၁၉၆၇
Headquartersဗန်ကူးဗားမြို့, ဗြိတိသျှ ကိုလံဘီယာ ပြည်နယ်, ကနေဒါ
Sector-
Websitereplicel.com